We read with great interest the article by Kim et al. (2009) in which the authors show an inverse relationship between high folate intake and colorectal cancer (CRC) risk in a casecontrol Korean population. This of course is a welcome study, particularly as most of the previous studies have addressed this issue in Western populations. The authors have been thorough in assessing for known co-variates, but a striking point is the lack of adjustment for fibre intake in this study. This is vital as the European Prospective Investigation into Cancer and Nutrition study (Bingham et al., 2003) has shown a strong protective effect of fibre against CRC, which subsequently held even after adjusting for total folate levels.
Until recently, folate was one of the nutrients most strongly implicated in terms of protection against CRC. An inverse relationship between folate intake and risk of colorectal adenoma was demonstrated in the Health Professionals Follow-Up study and in the Nurses Health study, in which the relative risk of adenomas was 0.66 for women and 0.63 for men in those with a higher intake of folate. Similarly, in a review of 11 case-control and cohort studies, a 40% risk reduction of CRC was seen in the highest consumers of folate. Conversely, recent results from the Polyp Prevention Group (Cole et al., 2007) have shown no reduction (relative risk 1.13 at 3-5 years follow-up) in risk of adenoma recurrence with folic acid supplementation (1 mg/day) even in susceptible individuals (those with low baseline folate status and those who consumed alcohol).
In this study by Kim et al. (2009) , it is not known whether any of the subjects had any form of colon screening undertaken prior to their diagnosis-specifically to identify precancerous lesions such as adenomas or even aberrant crypt foci. We have shown in a proposed model (folate 'seesaw' model) for CRC carcinogenesis (Arasaradnam et al., 2008) that folate status has the propensity to either promote or prevent carcinogenesis, which is largely determined by the presence of putative pre-cancerous lesions in colonocytes named aberrant crypt foci. Hence, prior identification of such lesions would have implications for the CRC risk based on folate intake.
Folate, through its role in the one-carbon metabolism, is crucial for both DNA synthesis as well as methylation with several other potential mechanisms of action. Issues surrounding folic acid and its effect on methylation and colorectal carcinogenesis remain complex. Folate seems protective against initiation of carcinogenesis, but also promotes carcinogenesis-for example, increase in mortality from breast cancer during pregnancy with folate supplementation. The way in which we consider alterations in folate status within colonocytes and its effect on carcinogenesis is important. For example, alteration in folate form and distribution (qualitative alterations) in relation to certain genotypes (MTHFR) might be more informative than total folate concentrations (quantitative changes) alone. Ongoing debate exists in Europe as to the rationale for folate fortification in foods; hence, long-term follow-up studies (both in individuals who are folate deplete and in those who are replete) are desperately required to determine the true effect of folate status on colon carcinogenesis.
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